Literature DB >> 1739608

The management of locally advanced breast cancer.

R D Rubens.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1739608      PMCID： PMC1977743          DOI： 10.1038/bjc.1992.31

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  19 in total

1.  The management of locally advanced breast cancer by X-ray therapy.

Authors:  A O Langlands; G R Kerr; S Shaw
Journal:  Clin Oncol       Date:  1976-12

2.  Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study.

Authors:  C Schaake-Koning; E H van der Linden; G Hart; E Engelsman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-10       Impact factor: 7.038

3.  Intraarterial induction chemotherapy in locally advanced stage III breast cancer.

Authors:  F O Stephens
Journal:  Cancer       Date:  1990-08-15       Impact factor: 6.860

Review 4.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.

Authors:  G N Hortobagyi; F C Ames; A U Buzdar; S W Kau; M D McNeese; D Paulus; V Hug; F A Holmes; M M Romsdahl; G Fraschini
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

5.  Toxicity of intra-arterial doxorubicin in locally advanced breast cancer.

Authors:  C J Twelves; M A Chaudary; J Reidy; M A Richards; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital.

Authors:  R Arriagada; H Mouriesse; D Sarrazin; R M Clark; G Deboer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-10       Impact factor: 7.038

7.  Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy.

Authors:  R Zucali; C Uslenghi; R Kenda; G Bonadonna
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

8.  Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months.

Authors:  L Israël; J L Breau; J F Morere
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

9.  Six-year results of a multimodality treatment strategy for locally advanced breast cancer.

Authors:  M J Piccart; D de Valeriola; R Paridaens; D Balikdjian; W H Mattheiem; C Loriaux; C Arrigo; F Cantraine; J C Heuson
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

10.  Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792).

Authors:  R D Rubens; H Bartelink; E Engelsman; J L Hayward; N Rotmensz; R Sylvester; E van der Schueren; J Papadiamantis; S D Vassilaros; J Wildiers
Journal:  Eur J Cancer Clin Oncol       Date:  1989-04
View more
  4 in total

1.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

2.  Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.

Authors:  Gengxi Cai; Zhanwen Guan; Yabin Jin; Zuhui Su; Xiangping Chen; Qing Liu; Chunlin Wang; Xiaoxia Yin; Lifang Zhang; Guolin Ye; Wei Luo
Journal:  JCO Precis Oncol       Date:  2022-01

3.  Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.

Authors:  J Brittenden; S D Heys; I Miller; T K Sarkar; A W Hutcheon; G Needham; F Gilbert; M McKean; A K Ah-See; O Eremin
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

4.  Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.

Authors:  J C Gazet; R C Coombes; H T Ford; M Griffin; C Corbishley; V Makinde; S Lowndes; J Quilliam; R Sutcliffe
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.